NATIONAL
CALIFORNIA
VENTURA
category
mechanism
- Stimulates alpha, beta-1, and beta-2 adrenergic receptors resulting in relaxation of smooth muscle of the bronchial tree
indications
- Croup, airway edema
contraindications
- Use with caution in patients with cardiovascular disease, diabetes, seizures and thyroid disease.
dosing
Pediatric
0.5 mL of 2.25% solution
administration
Nebulized: diluted in 2 to 3 mL of NS
onset
1 minute
duration
1-3 hours
notes
- Asthma: Not recommended for routine treatment of asthma
dosage form
2.25% (0.5mL vial)
adverse reactions
- Cardiovascular
- Tachycardia
- Central Nervous System
- Excitement
- Nervousness
- Tremor
- Anxiety
- Hyperactive behavior
- Insomnia
structure
